{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T12:39:22Z","timestamp":1726490362321},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Hand Surgery"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.jhsa.2012.11.023","type":"journal-article","created":{"date-parts":[[2013,1,9]],"date-time":"2013-01-09T15:01:11Z","timestamp":1357743671000},"page":"588-592","source":"Crossref","is-referenced-by-count":4,"title":["Pharmacologic Management of Osteoporosis"],"prefix":"10.1016","volume":"38","author":[{"given":"Michael","family":"Aynardi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asif M.","family":"Ilyas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jhsa.2012.11.023_bib1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF00296650","article-title":"Fracture of the distal forearm as a forecaster of subsequent hip fracture: a population-based cohort study with 24 years of follow-up","volume":"52","author":"Mallmin","year":"1993","journal-title":"Calcif Tissue Int"},{"issue":"843","key":"10.1016\/j.jhsa.2012.11.023_bib2","first-page":"1","article-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group","year":"1994","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"8","key":"10.1016\/j.jhsa.2012.11.023_bib3","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2106\/00004623-200008000-00001","article-title":"Treatment of osteoporosis: are physicians missing an opportunity?","volume":"82","author":"Freedman","year":"2000","journal-title":"J Bone Joint Surg Am"},{"issue":"10","key":"10.1016\/j.jhsa.2012.11.023_bib4","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/BOT.0b013e3181ba46d3","article-title":"Distal radius fractures","volume":"23","author":"Liporace","year":"2009","journal-title":"J Orthop Trauma"},{"issue":"4","key":"10.1016\/j.jhsa.2012.11.023_bib5","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2106\/JBJS.J.00303","article-title":"Osteoporosis as a risk factor for distal radial fractures","volume":"93","author":"Oyen","year":"2011","journal-title":"J Bone Joint Surg Am"},{"issue":"5","key":"10.1016\/j.jhsa.2012.11.023_bib6","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2106\/JBJS.G.01121","article-title":"Improving evaluation and treatment for osteoporosis following distal radius fractures","volume":"90","author":"Rozental","year":"2008","journal-title":"J Bone Joint Surg Am"},{"issue":"1","key":"10.1016\/j.jhsa.2012.11.023_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-008-0643-x","article-title":"Risk factors for low bone mass in healthy 40-60 year old women: a systematic review of the literature","volume":"20","author":"Waugh","year":"2009","journal-title":"Osteoporos Int"},{"year":"2010","series-title":"Clinician's Guide to Prevention and Treatment of Osteoporosis","key":"10.1016\/j.jhsa.2012.11.023_bib8"},{"issue":"3","key":"10.1016\/j.jhsa.2012.11.023_bib9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1359\/JBMR.051206","article-title":"Calcium and vitamin D3 fortified milk reduces bone loss at clinically relevant skeletal sites in older men: a 2 year randomized controlled trial","volume":"21","author":"Daly","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"23","key":"10.1016\/j.jhsa.2012.11.023_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJM199212033272305","article-title":"Vitamin D3 and calcium to prevent hip fractures in the elderly women","volume":"327","author":"Chapuy","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhsa.2012.11.023_bib11","doi-asserted-by":"crossref","first-page":"c3691","DOI":"10.1136\/bmj.c3691","article-title":"Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis","volume":"341","author":"Bolland","year":"2010","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.jhsa.2012.11.023_bib12","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/archinte.166.8.869","article-title":"Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women","volume":"166","author":"Prince","year":"2006","journal-title":"Arch Intern Med"},{"issue":"24","key":"10.1016\/j.jhsa.2012.11.023_bib13","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","article-title":"Effects of continuing or stopping alendronate after 5 years of treatment: The Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial","volume":"296","author":"Black","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jhsa.2012.11.023_bib14","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures: Fracture Intervention Trial Research Group","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.jhsa.2012.11.023_bib15","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: Results from the Fracture Intervention Trial","volume":"280","author":"Cummings","year":"1998","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.jhsa.2012.11.023_bib16","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","article-title":"Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis: The Alendronate Phase III Osteoporosis Treatment Study Group","volume":"333","author":"Liberman","year":"1995","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jhsa.2012.11.023_bib17","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jhsa.2008.12.011","article-title":"Comparison of radiographic fracture healing in the distal radius for patients on and off bisphosphonate therapy","volume":"34","author":"Rozental","year":"2009","journal-title":"J Hand Surg Am"},{"issue":"10","key":"10.1016\/j.jhsa.2012.11.023_bib18","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: Report of a task force of the American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.jhsa.2012.11.023_bib19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1302\/0301-620X.89B3.18146","article-title":"Subtrochanteric insufficiency fractures inpatients on alendronate therapy: A caution","volume":"89","author":"Goh","year":"2007","journal-title":"J Bone Joint Surg Br"},{"issue":"5","key":"10.1016\/j.jhsa.2012.11.023_bib20","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/BOT.0b013e318172841c","article-title":"Low-energy femoral shaft fractures associated with alendronate use","volume":"22","author":"Neviaser","year":"2008","journal-title":"J Orthop Trauma"},{"issue":"19","key":"10.1016\/j.jhsa.2012.11.023_bib21","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.jhsa.2012.11.023_bib22","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.2106\/JBJS.J.01379","article-title":"Parathyroid hormone 1\u201384 accelerates fracture-healing in pubic bones of elderly osteoporotic women","volume":"93","author":"Peichl","year":"2011","journal-title":"J Bone Joint Surg Am"},{"issue":"2","key":"10.1016\/j.jhsa.2012.11.023_bib23","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1359\/jbmr.061111","article-title":"Osteosarcoma and teriparatide?","volume":"22","author":"Harper","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"7","key":"10.1016\/j.jhsa.2012.11.023_bib24","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1359\/JBMR.040305","article-title":"A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women","volume":"19","author":"Bekker","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"8","key":"10.1016\/j.jhsa.2012.11.023_bib25","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMoa044459","article-title":"Denosumab in postmenopausal women with low bone mineral density","volume":"354","author":"McClung","year":"2006","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jhsa.2012.11.023_bib26","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jhsa.2012.11.023_bib27","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1359\/jbmr.081113","article-title":"Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing","volume":"24","author":"Gerstenfeld","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.jhsa.2012.11.023_bib28","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1210\/jc.85.5.1783","article-title":"Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women","volume":"85","author":"Downs","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.jhsa.2012.11.023_bib29","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1359\/jbmr.090315","article-title":"Comparative effects of teriparatide and strontium ranelate on bone biopsies and biochemical markers of bone turnover in postmenopausal women with osteoporosis","volume":"24","author":"Recker","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1016\/j.jhsa.2012.11.023_bib30","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/01.GME.0000119981.77837.1F","article-title":"Once-weekly alendronate 70 mg and raloxifene 60 mg daily in the treatment of postmenopausal osteoporosis","volume":"11","author":"Luckey","year":"2004","journal-title":"Menopause"}],"container-title":["The Journal of Hand Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0363502312017108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0363502312017108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T16:27:05Z","timestamp":1539966425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0363502312017108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0363502312017108"],"URL":"https:\/\/doi.org\/10.1016\/j.jhsa.2012.11.023","relation":{},"ISSN":["0363-5023"],"issn-type":[{"type":"print","value":"0363-5023"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}